The ASCO Post Podcast

Latest Episodes:

Genitourinary Cancers Symposium: Bladder and Kidney Cancers Research Feb 19, 2021

Show notes

The 2021 Genitourinary Cancers Symposium took place virtually from February 11 to 13. This week, we’re hearing from three authors of novel research in bladder and kidney cancers.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

IASLC WCLC 2020: Research in Mesothelioma, Small Cell Lung Cancer, and Drug Development Feb 12, 2021

Show notes

This week, we’re again focusing on research presented at the International Association for the Study of Lung Cancer 2020 World Conference on Lung Cancer Singapore, which was moved to a virtual format and held January 28 to 31, 2021, in light of the COVID-19 pandemic. We’ll hear about findings in mesothelioma, small cell lung cancer, and drug development.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

IASLC WCLC 2020: Updates From the ADAURA Trial and More Feb 05, 2021

Show notes

This week, we’re hearing from two thoracic oncologists on research presented at the International Association for the Study of Lung Cancer 2020 World Conference on Lung Cancer Singapore, which was moved to a virtual format and held January 28 to 31, 2021, in light of the COVID-19 pandemic.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

Prevalence of KRAS G12C Mutations Across Different Populations Jan 29, 2021

Show notes

This week, we’ll discuss the findings of a study that examined the prevalence of KRAS G12C mutations across different populations. Then, we’ll hear recent news about FDA oncology drug approvals in the month of January.

Coverage of stories discussed this week on ascopost.com:

Prevalence of KRAS G12C Somatic Mutations by Cancer Type, Race, and Sex

FDA Approves Crizotinib for Children and Young Adults With Relapsed or Refractory Systemic ALK -Positive ALCL

FDA Approves Fam-Trastuzumab Deruxtecan-nxki for Previously Treated Patients With HER2-Positive Gastric Cancers

FDA Approves Nivolumab Plus Cabozantinib for Advanced Renal Cell Carcinoma

To listen to more podcasts from ASCO, visit asco.org/podcasts.

More From GI21: Findings in Gastric Cancer, Cholangiocarcinoma, and Pancreatic Cancer Jan 22, 2021

Show notes

This week, we’re back for more coverage of the 2021 Gastrointestinal Cancers Symposium, hearing about the FIGHT trial in advanced gastric/gastroesophageal junction adenocarcinoma, the ClarIDHy study in IDH1-mutated cholangiocarcinoma, and the POLO trial in BRCA-mutated pancreatic cancer.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

Findings From the 2021 Gastrointestinal Cancers Symposium Jan 15, 2021

Show notes

The 2021 Gastrointestinal Cancers Symposium, held in a virtual format this year, is being held this weekend, January 15th to 17th, 2021. We’re discussing findings from the meeting with three study authors.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

IDEA Collaboration: 3 vs 6 Months of Adjuvant Chemotherapy for Patients With Advanced Colon Cancer Jan 08, 2021

Show notes

This week, we’ll review a meta-analysis of several trials studying the efficacy of 3 vs 6 months of adjuvant chemotherapy for patients with advanced colon cancer. We’ll also discuss a report on the frequency of osteonecrosis of the jaw among patients with metastatic bone disease treated with zoledronic acid, as well as several risk factors for the development of the condition.

Coverage of stories discussed this week on ascopost.com:

Final Overall Survival Results of the IDEA Collaboration: 3 vs 6 Months of Adjuvant Chemotherapy for Stage III Colon Cancer

Risk for Osteonecrosis of the Jaw After Treatment With Zoledronic Acid for Metastatic Bone Disease

To listen to more podcasts from ASCO, visit asco.org/podcasts.

News From the 2020 San Antonio Breast Cancer Symposium Dec 18, 2020

Show notes

The San Antonio Breast Cancer Symposium took place virtually from December 8 to 12th. This week, we’re featuring three important studies from the meeting, focusing on a new prognostic tool; the treatment of depression and related symptoms in young breast cancer survivors; and a chemoimmunotherapy regimen for triple-negative disease.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

More News From ASH: Whole-Genome Sequencing of Myeloproliferative Neoplasms and More Dec 11, 2020

Show notes

This week, we’ll focus further on studies presented at the 2020 ASH Annual Meeting & Exposition, including findings on the use of whole-genome sequencing to trace the origins of a blood cancer; stem cell transplant for older patients with myelodysplastic syndromes; and a triplet therapy for relapsed and refractory multiple myeloma.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

News From the 2020 ASH Annual Meeting & Exposition Dec 06, 2020

Show notes

The 2020 ASH Annual Meeting & Exposition, held in a virtual format this year, begins today. We’re featuring three studies on the podcast this week from the meeting.

To listen to more podcasts from ASCO, visit asco.org/podcasts.